Achieved positive net income and earnings per share one year ahead of internal expectations, marking a significant maturity milestone for the public company. Realized a 7% improvement in clinician productivity during the second half of 2025 by optimizing scheduling processes and implementing a new cash incentive program. Successfully balanced net clinician growth with existing capacity utilization to drive higher visits per clinician and improve overall operating leverage. Enhanced patient acquisiti ...